Answers are grounded in this paper and cite their sources.
People living with HIV (PLHIV) face a disproportionate tuberculosis (TB) burden. WHO recommends routine four-symptom TB screening at every HIV care visit. However, how well this recommendation translates into completed diagnostic evaluation and treatment in Uganda has not been comprehensively described using nationally representative data. We aimed to determine the prevalence and factors associated with a positive TB symptom screen and TB preventive therapy (TPT) uptake among PLHIV in HIV care. We conducted a secondary analysis of the Uganda Population-Based HIV Impact Assessment (UPHIA) 2020–2021, a nationally representative household survey. The analytic sample comprised PLHIV with a valid TB symptom screening result at their last HIV care visit. A positive TB symptom screen was defined as self-reported cough, fever, night sweats, or weight loss at that visit, and TPT uptake as self-reported ever having taken medicine to prevent TB. Factors associated with a positive screen and with TB preventive therapy uptake were examined using modified Poisson regression with jackknife variance, adjusted a priori for age, sex, residence, and region. A p < 0.05 was considered statistically significant. The weighted prevalence of a positive TB symptom screen was 59.3% (95% CI 56.2–62.4; 673/1,116 participants unweighted). In adjusted models, only region was independently associated with a positive screen, with higher prevalence in Mid North (adjusted prevalence ratio [aPR] 1.20, 95% CI 1.01–1.43, p = 0.040) and Northeast: Karamoja (aPR 1.29, 95% CI 1.01–1.65, p = 0.042) relative to Central 1: South Buganda. Of the 673 symptom-positive participants, 162 (weighted 26.2%, 95% CI 22.7–30.0) had a clinic visit, and 34 of the 161 with a recorded diagnostic outcome (weighted 22.4%, 95% CI 16.7–29.4) were diagnosed with TB. The weighted prevalence of TPT uptake among eligible PLHIV was 60.7% (95% CI 57.2–64.2; 652/1,072 unweighted), with modestly higher adjusted prevalence in Central 2: North Buganda relative to Central 1 (aPR 1.25, 95% CI 1.05–1.48, p = 0.012). TB symptom screening reaches most PLHIV in HIV care and identifies a substantial proportion as symptom-positive, but fewer than a third of these receive documented follow-up evaluation, and only a minority of those evaluated are ultimately diagnosed with TB. Strengthening referral and follow-through after a positive screen, and understanding the modest regional variation observed in TB preventive therapy uptake, are concrete targets for programmatic attention.
No takes yet. Share an insight, caveat, or question.
Okello et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: